Clinical Trials Logo

Clinical Trial Summary

This study is about the effect of dexmedetomidine to the stress of pituitrin in laparoscopic hysteromyoma surgery. It is well known that pituitrin has been widespread used in the laparoscopic hysteromyoma surgery. Pituitrin includes oxytocin and vasopressin. Vasopressin increase body stress reaction through hypothalamic pituitary adrenal(HPA) axis. The HPA axis has has main role to the body stress reaction. Dexmedetomidine can inhibit the stress responses mediated by the sympathetic nervous system. Therefore,the effect of dexmedetomidine to the stress of pituitrin in laparoscopic hysteromyoma surgery is worth to be studied.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03524950
Study type Interventional
Source Beijing Anzhen Hospital
Contact Xia Cao, M.D.Candidate
Phone +86-13811239739
Email 13811239739@139.com
Status Not yet recruiting
Phase Phase 3
Start date June 1, 2018
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT03251677 - Total Laparoscopic Hysterectomy vs Minilap Hysterectomy N/A
Not yet recruiting NCT05884658 - Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery Versus or Laparoscopic Hysterectomy N/A
Completed NCT03193177 - A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases